HQL (abrdn Life Sciences Investors) 3-Year Dividend Growth Rate: 7.40% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HQL abrdn Life Sciences Investors HQL
51 GF Score
Price $20.96
GF Value $62.01
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is abrdn Life Sciences Investors 3-Year Dividend Growth Rate?

abrdn Life Sciences Investors HQL -2.74% 51 3-Year Dividend Growth Rate is 7.40% as of Mar. 2026. GuruFocus rates HQL with a GF Score™ of 51/100 and a GF Value™ of $62.01 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 848 Asset Management companies, abrdn Life Sciences Investors ranks better than 64.39% on this metric.

abrdn Life Sciences Investors's Dividends per Share for the six months ended in Mar. 2026 was $1.06.

The historical rank and industry rank for abrdn Life Sciences Investors's 3-Year Dividend Growth Rate or its related term are showing as below:

HQL' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -4.5   Med: -0.3   Max: 7.4
Current: 7.4

During the past 9 years, the highest 3-Year average Dividends Per Share Growth Rate of abrdn Life Sciences Investors was 7.40% per year. The lowest was -4.50% per year. And the median was -0.30% per year.

HQL's 3-Year Dividend Growth Rate is ranked better than
64.39% of 848 companies
in the Asset Management industry
Industry Median: 3.8 vs HQL: 7.40

During the past 12 months, abrdn Life Sciences Investors's average Dividends Per Share Growth Rate was -1.50% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 7.40% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 2.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

abrdn Life Sciences Investors's Dividend Payout Ratio for the six months ended in Mar. 2026 was 0.49. As of today, abrdn Life Sciences Investors's Dividend Yield % is 10.69%.

Good Sign:

abrdn Life Sciences Investors stock Dividend Yield % is close to 1-year high.

For more information regarding to dividend, please check our Dividend Page.


abrdn Life Sciences Investors  (NYSE:HQL) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

abrdn Life Sciences Investors's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=1.06/ 2.15
=0.49

During the past 9 years, the highest Dividend Payout Ratio of abrdn Life Sciences Investors was 1.62. The lowest was 0.29. And the median was 0.63.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

abrdn Life Sciences Investors Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.6200002026-08-242026-08-242026-09-30Cash DividendquarterlyUSD:USD 1.000000
USD 0.5600002026-05-212026-05-212026-06-30Cash DividendquarterlyUSD:USD 1.000000
USD 0.5600002026-02-202026-02-202026-03-31Cash DividendquarterlyUSD:USD 1.000000
USD 0.5000002025-11-212025-11-212026-01-12Cash DividendquarterlyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

abrdn Life Sciences Investors's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=2.24/20.96
=10.69 %

Current Share Price is $20.96.
abrdn Life Sciences Investors's Dividends per Share for the trailing twelve months (TTM) ended in Today is $2.24.

During the past 9 years, the highest Dividend Yield of abrdn Life Sciences Investors was 14.51%. The lowest was 6.65%. And the median was 9.53%.

Good Sign:

abrdn Life Sciences Investors stock Dividend Yield % is close to 1-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


abrdn Life Sciences Investors 3-Year Dividend Growth Rate Related Terms>


HQL vs MUJ, ACP, NKX: 3-Year Dividend Growth Rate Comparison

For the Asset Management subindustry, abrdn Life Sciences Investors's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


abrdn Life Sciences Investors 3-Year Dividend Growth Rate vs Asset Management Industry

For the Asset Management industry and Financial Services sector, abrdn Life Sciences Investors's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where abrdn Life Sciences Investors's 3-Year Dividend Growth Rate falls into.


HQL
51GF Score
abrdn Life Sciences Investors HQL
3-Year Dividend Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

abrdn Life Sciences Investors 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

What does a 3-Year Dividend Growth Rate of 7.40% mean?
abrdn Life Sciences Investors (HQL) has a 3-Year Dividend Growth Rate of 7.40% as of Mar. 2026. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on abrdn Life Sciences Investors and its competitors. According to the industry distribution chart, abrdn Life Sciences Investors ranks #302 out of 848 companies in the Asset Management industry, placing it in the top 35.6%.
Is abrdn Life Sciences Investors' 3-Year Dividend Growth Rate too high?
abrdn Life Sciences Investors' current 3-Year Dividend Growth Rate is 7.40%. The Asset Management industry median 3-Year Dividend Growth Rate is 3.80. abrdn Life Sciences Investors' value of 7.40% is 94.7% above this industry median. Based on the distribution chart, abrdn Life Sciences Investors ranks #302 out of 848 companies in the Asset Management industry, which is above the industry midpoint. Overall, abrdn Life Sciences Investors has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does abrdn Life Sciences Investors' 3-Year Dividend Growth Rate compare to MUJ and ACP?
According to the Asset Management industry distribution chart, abrdn Life Sciences Investors ranks #302 out of 848 companies for 3-Year Dividend Growth Rate. This puts abrdn Life Sciences Investors in the upper half of its industry. The industry median 3-Year Dividend Growth Rate is 3.80. abrdn Life Sciences Investors' value of 7.40% is 94.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for an Asset Management company?
The median 3-Year Dividend Growth Rate among Asset Management companies is 3.80, based on 848 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. abrdn Life Sciences Investors's current 3-Year Dividend Growth Rate of 7.40% is 94.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on abrdn Life Sciences Investors and its competitors. For the Asset Management industry, the median 3-Year Dividend Growth Rate is 3.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. abrdn Life Sciences Investors's current 3-Year Dividend Growth Rate is 7.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Life Sciences Investors stock overvalued right now?
Based on GuruFocus' analysis, abrdn Life Sciences Investors (HQL) is currently considered Significantly Undervalued. The stock's GF Value™ is $62.01, compared to a current price of $20.96 — trading 66.2% below its estimated fair value. The current 3-Year Dividend Growth Rate is 7.40% and 94.7% above the Asset Management industry median of 3.80. abrdn Life Sciences Investors' overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For abrdn Life Sciences Investors (HQL), the current 3-Year Dividend Growth Rate is 7.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is abrdn Life Sciences Investors (HQL) Overvalued in 2026?

Based on GuruFocus' analysis, abrdn Life Sciences Investors stock appears to be undervalued. The current stock price of $20.96 is trading 66.2% below its estimated GF Value™ of $62.01. GuruFocus considers abrdn Life Sciences Investors to be Significantly Undervalued.

Key valuation signals for HQL:

  • 3-Year Dividend Growth Rate: 7.40%
  • GF Value™: $62.01 vs. price of $20.96 (66.2% below fair value)
  • GF Score™: 51/100 with 4 warning signs
  • Industry Position: 94.7% above the Asset Management median (#302 of 848)

No single metric tells the full story. See the HQL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


abrdn Life Sciences Investors Business Description

Address 1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
51GF Score

Get the complete analysis for HQL

3-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.96
Price
$62.01
GF Value